ArriVent BioPharma (AVBP) Share-based Compensation (2023 - 2026)
ArriVent BioPharma (AVBP) recorded Share-based Compensation of $6.67 million in Q2 2026, up 101.3% from $3.31 million a year earlier and up 21.5% from the prior quarter.
Powered by 
Analysis
ArriVent BioPharma (AVBP) Share-based Compensation (2023 - 2026) Analysis & Trends
On a TTM basis, ArriVent BioPharma's Share-based Compensation came in at $19.09 million as of Jun 30, 2026, up 157.9% year-over-year; for FY2025, it came in at $12.52 million, up 290.3% from FY2024.
- Across earlier years, Share-based Compensation came in at $3.21 million in FY2024 (+258.4%) and $895,000 in FY2023.
- The Q2 2026 figure is the highest quarterly Share-based Compensation in data going back to Q1 2023.
- On a year-over-year basis, Share-based Compensation has increased for ten consecutive quarters, with growth averaging 238.0% over the last eight quarters.
- The year-over-year growth in Share-based Compensation has ranged between 101.3% (Q2 2026) and 332.8% (Q2 2025) over the last five years.
- Per Business Quant, the preceding three quarters came in at $5.49 million (Q1 2026), $3.22 million (Q4 2025) and $3.72 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 249.00 Mn |
| 10 | ArriVent BioPharma | 909.29 Mn | -403.30 Mn | - | 6.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.67 Mn |
| Mar 31, 2026 | 5.49 Mn |
| Dec 31, 2025 | 3.22 Mn |
| Sep 30, 2025 | 3.72 Mn |
| Jun 30, 2025 | 3.31 Mn |
| Mar 31, 2025 | 2.27 Mn |
| Dec 31, 2024 | 951,000.00 |
| Sep 30, 2024 | 865,000.00 |
| Jun 30, 2024 | 766,000.00 |
| Mar 31, 2024 | 625,000.00 |
| Dec 31, 2023 | 319,000.00 |
| Sep 30, 2023 | 216.00 Mn |
| Jun 30, 2023 | 193.00 Mn |
| Mar 31, 2023 | 166,000.00 |
API Access
ArriVent BioPharma Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=AVBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "AVBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=AVBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();